Via a tweet from Kyle Scott of Crossing Broad, we are led to this press release which, after I checked it out on the company’s website, appears to be legit:
FT. LAUDERDALE, Jan. 15, 2013 – Retired former Chicago Cubs sports legend and entrepreneur Sammy Sosa has purchased the distribution rights for North America and Latin America, excluding Brazil, for the needle-free injection system known as Injex21.
Mr. Sosa was introduced to the Injex system in mid-2012, when he immediately saw the potential to help millions of people around the world who are forced to take painful injections, who are afraid of injections or who subject themselves to daily self-injections. Medical workers, as well, can reduce the risk of puncture wounds.
I know nothing about this product, but if it helps anyone get needed medication easier, good for Sammy Sosa, no matter how many insanely easy punchlines it encourages.
Both a Kinsler and a Kintzler made headlines at the Winter Meetings. After the Angels acquired second baseman Ian Kinsler from the Tigers, Ken Rosenthal of The Athletic reports that the Nationals have inked reliever Brandon Kintzler to a two-year contract, pending a physical. Bob Nightengale of USA TODAY Sports reports that the deal is worth $10 million and includes a third-year option worth $6 million.
Kintzler, 33, spent the latter half of his 2017 campaign with the Nationals after the Twins traded him. Between both clubs, he put up an aggregate 3.03 ERA with 29 saves and a 39/16 K/BB ratio in 71 1/3 innings.
Sean Doolittle will handle save situations for the Nationals. Kintzler and Ryan Madson will bridge the gap to him in the seventh and eighth innings.